Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

pharmacia laboratories limited - emepronium bromide - tablets - 100 milligram

Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

pharmacia laboratories limited - emepronium bromide - tablets - 200 milligram

Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

pharmacia laboratories limited - emepronium carrageenate - tablets - 250 milligram

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

pharmacia limited company trading as pharmacia - emepronium carrageenate 333mg equivalent to 200 mg emepronium bromide - tablet - 200 mg - active: emepronium carrageenate 333mg equivalent to 200 mg emepronium bromide excipient: colloidal silicon dioxide crospovidone ethylcellulose glycerol hyprolose macrogol 8000 magnesium stearate   microcrystalline cellulose sorbitan oleate titanium dioxide vanillin

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

neo health (otc) pty ltd - cetirizine hydrochloride, quantity: 1 mg/ml - oral liquid - excipient ingredients: glycerol; saccharin sodium; sodium acetate trihydrate; sodium propyl hydroxybenzoate; sorbitol solution (70 per cent) (non-crystallising); purified water; propylene glycol; glacial acetic acid; sodium methyl hydroxybenzoate; flavour - seasonal allergic rhinitis: cetirizine is indicated for the relief of symptoms associated with season allergic rhinitis (hayfever) in adults and children aged 2-12 years. symptoms treated effectively include sneezing, rhinorrhoea, post-nasal discharge, nasal pruritus, occular pruritus and tearing and redness of the eyes. perennial allergic rhinitis: cetirizine is indicated for the relief of symptoms associated with perennial allergic rhinitis in adults and children aged 2-12 years. symptoms treated effectively include sneezing, rhinorrhoea, post-nasal discharge, nasal pruritus, ocular pruritus and tearing. chronic idiopathic urticaria: cetirizine is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children aged 2-12 years. it significantly reduces the occurrence, severity and duration of hives and markedly reduces pruritus.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

noumed pharmaceuticals pty ltd - cetirizine hydrochloride, quantity: 1 mg/ml - oral liquid - excipient ingredients: purified water; propyl hydroxybenzoate; glacial acetic acid; sodium acetate trihydrate; methyl hydroxybenzoate; saccharin sodium; propylene glycol; glycerol; sorbitol solution (70 per cent) (non-crystallising); flavour - seasonal allergic rhinitis: cetirizine is indicated for the relief of symptoms associated with seasonal allergic rhinitis (hay fever) in adults and children aged 1-12 years. symptoms treated effectively include sneezing, rhinorrhoea, post-nasal discharge, nasal pruritus, ocular pruritus and tearing and redness of the eyes. perennial allergic rhinitis: cetirizine is indicated for the relief of symptoms associated with perennial allergic rhinitis in adults and children aged 1-12 years. symptoms treated effectively include sneezing, rhinorrhoea, post-nasal discharge, nasal pruritus, ocular pruritus and tearing. chronic idiopathic urticaria: cetirizine is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children aged 1-12 years. it significantly reduces the occurrence, severity and duration of hives and markedly reduces pruritus. as with other antihistamines, patients should be advised to seek medical advice about the possibility that their urticaria is associated with ingestion of certain foods.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

noumed pharmaceuticals pty ltd - cetirizine hydrochloride, quantity: 1 mg/ml - oral liquid - excipient ingredients: propylene glycol; glacial acetic acid; glycerol; propyl hydroxybenzoate; purified water; sorbitol solution (70 per cent) (non-crystallising); sodium acetate trihydrate; saccharin sodium; methyl hydroxybenzoate; flavour - seasonal allergic rhinitis: cetirizine is indicated for the relief of symptoms associated with seasonal allergic rhinitis (hay fever) in adults and children aged 1-12 years. symptoms treated effectively include sneezing, rhinorrhoea, post-nasal discharge, nasal pruritus, ocular pruritus and tearing and redness of the eyes. perennial allergic rhinitis: cetirizine is indicated for the relief of symptoms associated with perennial allergic rhinitis in adults and children aged 1-12 years. symptoms treated effectively include sneezing, rhinorrhoea, post-nasal discharge, nasal pruritus, ocular pruritus and tearing. chronic idiopathic urticaria: cetirizine is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children aged 1-12 years. it significantly reduces the occurrence, severity and duration of hives and markedly reduces pruritus. as with other antihistamines, patients should be advised to seek medical advice about the possibility that their urticaria is associated with ingestion of certain foods.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

noumed pharmaceuticals pty ltd - cetirizine hydrochloride, quantity: 1 mg/ml - oral liquid - excipient ingredients: propyl hydroxybenzoate; sorbitol solution (70 per cent) (non-crystallising); methyl hydroxybenzoate; glacial acetic acid; sodium acetate trihydrate; purified water; propylene glycol; saccharin sodium; glycerol; flavour - seasonal allergic rhinitis: cetirizine is indicated for the relief of symptoms associated with seasonal allergic rhinitis (hay fever) in adults and children aged 1-12 years. symptoms treated effectively include sneezing, rhinorrhoea, post-nasal discharge, nasal pruritus, ocular pruritus and tearing and redness of the eyes. perennial allergic rhinitis: cetirizine is indicated for the relief of symptoms associated with perennial allergic rhinitis in adults and children aged 1-12 years. symptoms treated effectively include sneezing, rhinorrhoea, post-nasal discharge, nasal pruritus, ocular pruritus and tearing. chronic idiopathic urticaria: cetirizine is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children aged 1-12 years. it significantly reduces the occurrence, severity and duration of hives and markedly reduces pruritus. as with other antihistamines, patients should be advised to seek medical advice about the possibility that their urticaria is associated with ingestion of certain foods.

Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - cetirizine hydrochloride - oral tablet - 10mg

Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - cetirizine hydrochloride - oral tablet - 10mg